Acurx Common Stock vs Short Term Debt Analysis

ACXP Stock

USD 1.32 0.03 2.22%

Acurx Pharmaceuticals financial indicator trend analysis is way more than just evaluating Acurx Pharmaceuticals LLC prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Acurx Pharmaceuticals LLC is a good investment. Please check the relationship between Acurx Pharmaceuticals Common Stock and its Short Term Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acurx Pharmaceuticals LLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Common Stock vs Short Term Debt

Common Stock vs Short Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Acurx Pharmaceuticals LLC Common Stock account and Short Term Debt. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Acurx Pharmaceuticals' Common Stock and Short Term Debt is 0.58. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of Acurx Pharmaceuticals LLC, assuming nothing else is changed. The correlation between historical values of Acurx Pharmaceuticals' Common Stock and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of Acurx Pharmaceuticals LLC are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Common Stock i.e., Acurx Pharmaceuticals' Common Stock and Short Term Debt go up and down completely randomly.

Correlation Coefficient

0.58

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Common Stock

Short Term Debt

Most indicators from Acurx Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Acurx Pharmaceuticals LLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acurx Pharmaceuticals LLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

At this time, Acurx Pharmaceuticals' Selling General Administrative is relatively stable compared to the past year. As of 11/26/2024, Issuance Of Capital Stock is likely to grow to about 4.9 M, while Enterprise Value Over EBITDA is likely to drop (2.65).

Acurx Pharmaceuticals fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Common Stock	Short Long Term Debt Total	Long Term Debt	Short Long Term Debt	Short Term Debt	Other Assets	Net Receivables
Total Assets		-0.02	0.01	0.99	0.98	-1.0	-0.76	0.6	1.0	1.0	0.79	0.57	0.96	0.81	0.01	0.54	1.0	-0.87	0.99	-0.87	-0.38	-0.38	-0.38	-0.38	-0.55	-0.38
Other Current Liab	-0.02		1.0	-0.18	0.01	0.02	-0.42	-0.68	-0.03	-0.03	0.04	0.61	-0.09	0.35	1.0	0.46	-0.02	-0.43	-0.18	-0.43	-0.35	-0.35	-0.35	-0.35	-0.31	-0.35
Total Current Liabilities	0.01	1.0		-0.15	0.04	-0.01	-0.45	-0.66	0.0	0.0	0.07	0.63	-0.06	0.37	1.0	0.47	0.01	-0.45	-0.15	-0.45	-0.36	-0.36	-0.36	-0.36	-0.33	-0.36
Total Stockholder Equity	0.99	-0.18	-0.15		0.97	-0.99	-0.68	0.7	0.99	0.99	0.77	0.46	0.96	0.74	-0.15	0.46	0.99	-0.79	1.0	-0.79	-0.32	-0.32	-0.32	-0.32	-0.49	-0.32
Net Tangible Assets	0.98	0.01	0.04	0.97		-0.98	-0.79	0.62	0.98	0.98	0.86	0.64	0.9	0.8	0.04	0.61	0.98	-0.84	0.97	-0.84	-0.41	-0.41	-0.41	-0.41	-0.48	-0.41
Net Debt	-1.0	0.02	-0.01	-0.99	-0.98		0.76	-0.6	-1.0	-1.0	-0.79	-0.57	-0.96	-0.81	-0.01	-0.54	-1.0	0.87	-0.99	0.87	0.39	0.39	0.39	0.39	0.55	0.39
Retained Earnings	-0.76	-0.42	-0.45	-0.68	-0.79	0.76		-0.21	-0.75	-0.75	-0.83	-0.95	-0.66	-0.88	-0.45	-0.91	-0.76	0.86	-0.68	0.86	0.79	0.79	0.79	0.79	0.7	0.79
Accounts Payable	0.6	-0.68	-0.66	0.7	0.62	-0.6	-0.21		0.61	0.61	0.67	0.0	0.59	0.35	-0.65	0.0	0.6	-0.14	0.7	-0.14	0.12	0.12	0.12	0.12	-0.15	0.12
Cash	1.0	-0.03	0.0	0.99	0.98	-1.0	-0.75	0.61		1.0	0.79	0.56	0.96	0.81	0.0	0.54	1.0	-0.87	0.99	-0.87	-0.38	-0.38	-0.38	-0.38	-0.55	-0.38
Cash And Short Term Investments	1.0	-0.03	0.0	0.99	0.98	-1.0	-0.75	0.61	1.0		0.79	0.56	0.96	0.81	0.0	0.54	1.0	-0.87	0.99	-0.87	-0.38	-0.38	-0.38	-0.38	-0.55	-0.38
Common Stock Total Equity	0.79	0.04	0.07	0.77	0.86	-0.79	-0.83	0.67	0.79	0.79		0.73	0.68	0.81	0.08	0.65	0.79	-0.63	0.77	-0.63	-0.44	-0.44	-0.44	-0.44	-0.53	-0.44
Common Stock Shares Outstanding	0.57	0.61	0.63	0.46	0.64	-0.57	-0.95	0.0	0.56	0.56	0.73		0.41	0.74	0.64	0.95	0.57	-0.76	0.46	-0.76	-0.81	-0.81	-0.81	-0.81	-0.54	-0.81
Other Current Assets	0.96	-0.09	-0.06	0.96	0.9	-0.96	-0.66	0.59	0.96	0.96	0.68	0.41		0.82	-0.06	0.37	0.96	-0.83	0.96	-0.83	-0.26	-0.26	-0.26	-0.26	-0.66	-0.26
Other Stockholder Equity	0.81	0.35	0.37	0.74	0.8	-0.81	-0.88	0.35	0.81	0.81	0.81	0.74	0.82		0.38	0.6	0.81	-0.85	0.74	-0.85	-0.44	-0.44	-0.44	-0.44	-0.88	-0.44
Total Liab	0.01	1.0	1.0	-0.15	0.04	-0.01	-0.45	-0.65	0.0	0.0	0.08	0.64	-0.06	0.38		0.48	0.01	-0.45	-0.15	-0.45	-0.37	-0.37	-0.37	-0.37	-0.33	-0.37
Net Invested Capital	0.54	0.46	0.47	0.46	0.61	-0.54	-0.91	0.0	0.54	0.54	0.65	0.95	0.37	0.6	0.48		0.54	-0.71	0.46	-0.71	-0.94	-0.94	-0.94	-0.94	-0.42	-0.94
Total Current Assets	1.0	-0.02	0.01	0.99	0.98	-1.0	-0.76	0.6	1.0	1.0	0.79	0.57	0.96	0.81	0.01	0.54		-0.87	0.99	-0.87	-0.38	-0.38	-0.38	-0.38	-0.55	-0.38
Capital Stock	-0.87	-0.43	-0.45	-0.79	-0.84	0.87	0.86	-0.14	-0.87	-0.87	-0.63	-0.76	-0.83	-0.85	-0.45	-0.71	-0.87		-0.79	1.0	0.58	0.58	0.58	0.58	0.66	0.58
Net Working Capital	0.99	-0.18	-0.15	1.0	0.97	-0.99	-0.68	0.7	0.99	0.99	0.77	0.46	0.96	0.74	-0.15	0.46	0.99	-0.79		-0.79	-0.32	-0.32	-0.32	-0.32	-0.49	-0.32
Common Stock	-0.87	-0.43	-0.45	-0.79	-0.84	0.87	0.86	-0.14	-0.87	-0.87	-0.63	-0.76	-0.83	-0.85	-0.45	-0.71	-0.87	1.0	-0.79		0.58	0.58	0.58	0.58	0.66	0.58
Short Long Term Debt Total	-0.38	-0.35	-0.36	-0.32	-0.41	0.39	0.79	0.12	-0.38	-0.38	-0.44	-0.81	-0.26	-0.44	-0.37	-0.94	-0.38	0.58	-0.32	0.58		1.0	1.0	1.0	0.41	1.0
Long Term Debt	-0.38	-0.35	-0.36	-0.32	-0.41	0.39	0.79	0.12	-0.38	-0.38	-0.44	-0.81	-0.26	-0.44	-0.37	-0.94	-0.38	0.58	-0.32	0.58	1.0		1.0	1.0	0.41	1.0
Short Long Term Debt	-0.38	-0.35	-0.36	-0.32	-0.41	0.39	0.79	0.12	-0.38	-0.38	-0.44	-0.81	-0.26	-0.44	-0.37	-0.94	-0.38	0.58	-0.32	0.58	1.0	1.0		1.0	0.41	1.0
Short Term Debt	-0.38	-0.35	-0.36	-0.32	-0.41	0.39	0.79	0.12	-0.38	-0.38	-0.44	-0.81	-0.26	-0.44	-0.37	-0.94	-0.38	0.58	-0.32	0.58	1.0	1.0	1.0		0.41	1.0
Other Assets	-0.55	-0.31	-0.33	-0.49	-0.48	0.55	0.7	-0.15	-0.55	-0.55	-0.53	-0.54	-0.66	-0.88	-0.33	-0.42	-0.55	0.66	-0.49	0.66	0.41	0.41	0.41	0.41		0.41
Net Receivables	-0.38	-0.35	-0.36	-0.32	-0.41	0.39	0.79	0.12	-0.38	-0.38	-0.44	-0.81	-0.26	-0.44	-0.37	-0.94	-0.38	0.58	-0.32	0.58	1.0	1.0	1.0	1.0	0.41

Click cells to compare fundamentals

Acurx Pharmaceuticals Account Relationship Matchups

Pair Trading with Acurx Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acurx Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acurx Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Acurx Stock

0.76	ME	23Andme Holding	Pair Corr
0.76	VALN	Valneva SE ADR	Pair Corr
0.65	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr

Moving against Acurx Stock

0.65	RNXT	RenovoRx	Pair Corr
0.6	MDGL	Madrigal Pharmaceuticals	Pair Corr
0.38	KEP	Korea Electric Power	Pair Corr

The ability to find closely correlated positions to Acurx Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acurx Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acurx Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acurx Pharmaceuticals LLC to buy it.

The correlation of Acurx Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acurx Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acurx Pharmaceuticals LLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Acurx Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Acurx Stock Analysis

When running Acurx Pharmaceuticals' price analysis, check to measure Acurx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acurx Pharmaceuticals is operating at the current time. Most of Acurx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acurx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acurx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acurx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC